At a private hospital in Sutton Coldfield, a quiet but consequential threshold has been crossed: more than a thousand patients have now had their hips and knees remade with the guidance of a robotic system that sees more precisely than the unaided hand. Since 2018, Spire Little Aston's Mako programme has refined what joint replacement can mean — less pain, faster return, and a more faithful restoration of the life a person knew before their body began to fail them. In the story of medicine, this milestone is a reminder that technology earns its place not in the operating theatre alone, but in
Spire Little Aston marks 1,000th robotic joint replacement surgery
He left his crutches behind without even noticing
Mark
So they've done a thousand of these surgeries. What does that number actually tell us? Is it a lot?
Mimi
For a single private hospital over seven years, it's substantial. That's roughly 140 surgeries per year, which suggests they've built real expertise and volume with the technology.
Luke
But we should note—the source doesn't compare this to other hospitals or to how many traditional joint replacements they do. We don't know if Mako represents 50 percent of their joint work or 10 percent. The number feels big in isolation, but context matters.
Mark
Fair point. What about the patient outcome claims? Faster recovery, less pain—are those proven?
Mimi
The source cites benefits like increased precision, reduced pain, and faster recovery, and Giddins' experience bears that out. He was off crutches in two weeks and cycling 50 miles a day within months. That's real.
Luke
But that's one patient's story, and a very positive one. The source doesn't provide clinical data—no study results, no complication rates, no comparison group. We're relying on the hospital's claims and one anecdote, both of which have obvious incentives to be positive.
Mark
So we don't actually know how Mako compares to traditional surgery in terms of outcomes?
Mimi
Not from this reporting. The hospital says it's better. Giddins' recovery was excellent. But you're right—we'd need independent data to know if that's typical or exceptional.
Luke
And there's another angle: Giddins went private because the NHS said he wasn't ready. That raises a question the story doesn't explore. Why did he need to pay privately? What does that tell us about access?
Mark
Right. The technology exists, it works well for those who can afford it, but who actually gets it?
Mimi
That's the real story underneath this one—the gap between what's available and who can access it.
O Pulso
- A thousand patients had lived with the slow erosion of mobility — joints that gave way, stairs that became obstacles, and activities that quietly disappeared from their lives.
- For many, like Derek Giddins, years of NHS treatment offered no surgical relief, leaving them to manage decline rather than reverse it.
- The Mako robotic system offered a different path: real-time surgical guidance that preserves healthy tissue, reduces postoperative pain, and accelerates recovery beyond what conventional methods typically achieve.
- Giddins walked out of his kitchen two weeks after surgery having forgotten his crutches — his body had already begun to trust the new joint.
- Spire Little Aston's 1,000-surgery milestone signals that robotic-assisted orthopaedics is no longer experimental but is actively reshaping the standard of care expected across the region.
At a private hospital in Sutton Coldfield, a quiet but consequential threshold has been crossed: more than a thousand patients have now had their hips and knees remade with the guidance of a robotic system that sees more precisely than the unaided hand. Since 2018, Spire Little Aston's Mako programme has refined what joint replacement can mean — less pain, faster return, and a more faithful restoration of the life a person knew before their body began to fail them. In the story of medicine, this milestone is a reminder that technology earns its place not in the operating theatre alone, but in the moments afterwards, when a 77-year-old man cycles the Atlantic coast and forgets, for the first time in a decade, that his knee was ever broken.
Spire Little Aston Hospital in Sutton Coldfield has passed a significant threshold: more than 1,000 hip and knee replacements completed using the Mako robotic system since the technology was first introduced in 2018. Over seven years, the system has changed how orthopaedic surgeons work — offering real-time guidance that allows them to remove only damaged tissue, preserve what is healthy, and deliver outcomes that consistently outpace traditional joint replacement in speed of recovery and reduction of pain.
Derek Giddins, 77, represents what that difference looks like in a human life. For roughly a decade, his knee had been failing him — giving way unpredictably, slowly narrowing the range of things he could do. He cycled, swam, and climbed bell-tower stairs, but felt those possibilities shrinking. The NHS considered him not yet ready for surgery. When he came to Spire for a separate procedure and saw a poster about Mako-assisted knee replacement, he made a decision: when the time came, he would pursue it privately.
The surgery, performed by consultant James Arbuthnot, was followed by a recovery that surprised even Giddins. The pain was so minimal he barely touched his prescribed medication. Two weeks in, he walked into his kitchen and realised he had left his crutches in another room without noticing. Within weeks, he was back on his bike at Cannock Chase. On a recent trip to Portugal, he cycled up to 50 miles a day on an electric bike, climbing steep coastal roads — distances and terrain that had been unthinkable before.
Arbuthnot noted that the Mako system's value lies in its ability to tailor each procedure to the individual patient's anatomy, a personalisation that pays dividends in recovery. Hospital director Vicky Morris described the milestone as a reflection of the clinical team's sustained commitment since 2018. As robotic-assisted techniques grow more refined and more widely adopted, they are beginning to define a new baseline for what joint replacement surgery can and should deliver.
Spire Little Aston Hospital, a private facility in Sutton Coldfield, has now completed more than 1,000 hip and knee replacement surgeries using the Mako robotic system since first adopting the technology in 2018. The milestone marks seven years of refined surgical practice with a tool that has fundamentally altered how orthopedic surgeons approach joint replacement—allowing them to work with greater precision, minimize tissue damage, and send patients home with less pain and faster recovery than traditional methods permit.
The Mako system works by giving surgeons real-time guidance during surgery, enabling them to preserve healthy bone and tissue while removing only what is damaged. Patients who undergo Mako-assisted procedures typically experience reduced postoperative pain, quicker return to function, and improved long-term outcomes compared to conventional joint replacement. For a hospital serving both self-funded and insured patients, the technology has become a significant draw—a way to differentiate care and deliver measurable results.
Derek Giddins, 77, is one of those 1,000 patients. For a decade, starting around 2013, his knee had been failing him. He tried treatment through the NHS but found no relief. His knee would give way without warning. He managed to stay active—cycling, swimming, climbing stairs for his hobby of bell ringing—but he felt the walls closing in. The activities he loved were becoming harder to sustain. When he came to Spire for an earlier procedure, he spotted a poster advertising Mako-assisted knee replacement. It caught his attention. He decided that when the time came, he would pursue it privately, since the NHS had deemed him not yet ready for surgery.
Giddins underwent the procedure with consultant surgeon James Arbuthnot. What struck him most was not the surgery itself but what came after. The pain was minimal—so minimal that he barely needed the medication prescribed for recovery. Two weeks post-operation, he walked into his kitchen and suddenly realized he had left his crutches behind without thinking about it. That moment, he said, felt like a turning point. His body had already begun to trust the new joint.
Within weeks, his life expanded again. He returned to off-road cycling in Cannock Chase. Stairs no longer posed a problem. On a recent trip to Portugal, he cycled up to 50 miles a day on an electric bike, tackling steep climbs along the Atlantic coast—distances and terrain that would have been impossible before surgery. The new knee had given him back not just mobility but the freedom to live as he wanted.
Arbuthnot, reflecting on the milestone, emphasized that the Mako system allows surgeons to tailor each procedure to the individual patient's anatomy and needs. That personalization, he noted, translates directly into better recovery and stronger long-term outcomes. Vicky Morris, the hospital's director, framed the 1,000-surgery milestone as validation of the team's commitment to excellence since 2018. She credited the consultant surgeons and clinical staff whose expertise and dedication made the achievement possible.
The milestone is significant not just for Spire Little Aston but for the broader landscape of orthopedic surgery in the region. As robotic-assisted techniques become more refined and more hospitals adopt them, they are beginning to set a new standard for what joint replacement can deliver. Patients like Giddins—people who have lived with pain and limitation—now have access to a tool that can restore not just function but the ability to pursue the life they want to live.
Citações Notáveis
The new knee has certainly allowed me to keep doing what I love. I'm cycling off-road again in Cannock Chase, I can manage stairs for bell ringing with no problem, and on a recent trip to Portugal, I was cycling up to 50 miles a day on an e-bike along the Atlantic coast.— Derek Giddins, patient
The Mako robotic-assisted system allows us to deliver a more personalised approach, which can mean improved recovery and excellent long-term outcomes.— James Arbuthnot, consultant orthopaedic surgeon
Quer a matéria completa?
Leia o original em Express & Star ↗
Health & Medicine